India Hosts "Jaipur Foot" Camp in Kabul, Gives Prosthetic Limbs To Afghan Amputees
In a post on X (formerly Twitter), Ministry of External Affairs (MEA) Spokesperson Randhir Jaiswal wrote, "As part of India's ongoing humanitarian assistance to the people of Afghanistan, a five-day Jaipur Foot camp was organised in Kabul by BMVSS, Jaipur."
"The camp saw an enthusiastic response, with around 75 prosthetic limbs successfully fitted."
As part of India's ongoing humanitarian assistance to the people of Afghanistan, a five-day Jaipur Foot camp was organised in Kabul by BMVSS, Jaipur.
The camp saw an enthusiastic response, with around 75 prosthetic limbs successfully fitted. pic.twitter.com/LPlvcma6C3
— Randhir Jaiswal (@MEAIndia) June 29, 2025
The camp was organised by Bhagwan Mahaveer Viklang Sahayata Samiti (BMVSS), which is a not-for-profit organisation. It has served over 2.2 million beneficiaries worldwide in India and the world by providing limbs and other aids free of cost.
On Mr Jaiswal's post, one user wrote, "As an Afghan, I sincerely thank the people and Government of India for organizing the Jaipur Foot camp in Kabul. Providing prosthetic limbs to 75 Afghans is a kind and humanitarian gesture we deeply appreciate." "India has always been a good friend of Afghan people," another user said.
India's humanitarian aid to Afghanistan
From the COVID-19 pandemic to infrastructure development, India has been providing significant humanitarian aid to Afghanistan, demonstrating its commitment to supporting the country's people.
India further plans to engage in development projects, focusing on areas such as healthcare and education. New Delhi also provides scholarships and training programmes, aiming to build capacity and promote economic development.
Earlier this year, in April, India sent a shipment of 4.8 tonnes of vaccines to Afghanistan, which included rabies, tetanus, hepatitis B and influenza vaccines.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
New Indian Express
an hour ago
- New Indian Express
CM Rekha Gupta seeks doctors' support to turn city into medical hub
NEW DELHI: CM Rekha Gupta on Tuesday sought the support of doctors in transforming the national capital into a medical hub on the occasion of National Doctors' Day. Interacting with doctors at the Delhi Secretariat, she acknowledged their invaluable contribution to society. Addressing the gathering, Gupta said, 'A doctor is not just a professional, but a divine figure. When the thread of life weakens, it is the doctor's hand that holds it together. Doctors are the backbone of India's healthcare system.' She described doctors as 'representatives of God' and recalled their tireless and fearless service during the Covid-19 crisis. She emphasised that doctors remain committed to their patients, regardless of the hour or emergency. Expressing concern over the gap between the glorified health model of previous governments and the ground reality, she said many medical students still live in dilapidated hostels. Highlighting infrastructure challenges, the CM noted that Delhi currently has only 0.42 government hospital beds per 1,000 citizens. However, the government aims to raise this to at least 3 beds per 1,000 within five years. Gupta shared that, for the first time, 1,500 nurses have been given permanent appointments—pending for the past 15 years. Additionally, 24 hospital campuses shut for over two decades are now being revived. Every hospital will now have a dedicated superintendent for better accountability. Modern machines such as CT scans, MRIs, and ultrasounds are being fast-tracked. She added that Jan Aushadhi Kendras are being opened in all government hospitals, with 17 already functional. Basic amenities like clean toilets, waiting areas, and drinking water are also being upgraded.
India Today
an hour ago
- India Today
Shubhanshu Shukla's space mission could rewrite the rules of diabetes care. Here's how
Indian astronaut Shubhanshu Shukla is currently part of a historic mission aboard the International Space Station (ISS), participating in over 60 scientific experiments as part of the Axiom Mission 4 (Ax-4). Among them is a study that could reshape how we understand and manage diabetes: not just in space, but also on years, people with insulin-dependent diabetes have been excluded from space missions because of the challenges of managing blood sugar levels in a zero-gravity environment. The Ax-4 mission is now rethinking that 'SUITE RIDE' PROJECT: A STEP TOWARD INCLUSION A major highlight of the Ax-4 mission is a research project called Suite Ride, designed to study how glucose metabolism is affected by ultimate goal is to make it safe for people with diabetes to live and work in space."Suite Ride is investigating how the space environment affects glucose metabolism in the human body. This can enhance our understanding of diabetes and other metabolic diseases that impact blood sugar regulation," Dr. Mohammad Fityan, Clinical Lead for the Suite Ride project (Ax-4) from Burjeel Holdings, Chief Medical Officer, Burjeel Medical City, told Dr. Mohammad Fityan (right), Clinical Lead of the Burjeel–Ax-4 Space Health Research, with Gavin D'Elia (L), Global Head Of Pharma at Axiom Space and Dr. Lucie Low, Chief Scientist for Axiom Space at Kennedy Space Center. advertisementBurjeel Holdings, the research collaborator behind the project, partnered with Axiom Space to explore how Continuous Glucose Monitors (CGMs) and insulin fare in space. These tools are already revolutionising diabetes care on SPACE IS A GAME-CHANGER FOR DIABETES RESEARCHMicrogravity provides an environment that allows scientists to study the body without the usual gravitational pressures. This makes it possible to observe glucose metabolism in an entirely new light."Microgravity allows us to study metabolism without the influence of gravity. Changes in muscle mass, fluid distribution, and circadian rhythm offer new insights into glucose metabolism and insulin sensitivity. This may lead to the identification of novel pathways and early biomarkers for insulin resistance," said Dr. studying healthy individuals in space, scientists can create a foundation for understanding how diabetes behaves in such conditions, an essential step toward future space travel for those with chronic THE STUDY WORKS ABOARD ISSDuring the two-week mission, one or more astronauts are wearing CGMs for the entire duration. These devices continuously monitor blood glucose levels and send data back to Earth. The Ax-4 crew members aboard the International Space Station. (Photo: Nasa) "One or more astronauts are wearing CGMs for the entire duration of the mission. Readings are continuously monitored, and data is being collected. Insulin pens were sent on the flight, but astronauts are not using them. We are testing the viability and stability of insulin in the space environment. Point-of-care blood samples are also being taken during the mission to validate glucose levels. Lancets, needles, and blood glucose analyzers (i-STAT) were provided by Burjeel Holdings," said Dr. BARRIERS FOR DIABETICS IN SPACEDr. Fityan explained the current barriers that keep people with diabetes from going to space:Glucose variability and hypoglycemia can be life-threatening in space, where immediate medical help isn't challenges due to storage temperatures, fluid shifts, and inconsistent absorption in need for extremely accurate glucose control, which is hard to maintain on long Ax-4 mission is helping scientists understand how healthy metabolism behaves in microgravity and whether CGMs can be safely used by astronauts with diabetes in future CARE ON EARTHThe findings from Ax-4 are not just for future astronauts. They could also benefit people on Earth, especially in remote or underserved areas. advertisementThis study could lead to:Remote monitoring platforms for real-time metabolic glucose monitors for extreme or low-resource predictive models for personal diabetes drug targets to improve insulin sensitivity."This research helps expand eligibility for spaceflight, not by lowering standards, but by creating technologies and protocols that enable safe participation for individuals with chronic conditions, such as insulin-dependent diabetes," Dr. Fityan told NEXT?Once the mission returns, researchers will analyse the data to determine the next steps."We hope this research opens the door to future studies, including sending the first astronaut with diabetes into space and exploring other metabolic and chronic conditions," said Dr. Ax-4 mission, with Shubhanshu Shukla on board, could mark a historic event, one where space is accessible even for those managing chronic conditions like diabetes, and where the lessons from above help save lives back on Earth.- EndsTune InMust Watch
News18
an hour ago
- News18
‘Risky Lifestyle…': Health Ministry Clarifies No Links Between Covid Vaccines And Sudden Deaths
The health ministry noted that the studies have shown that the sudden cardiac deaths can result from a wide range of factors, including genetics, lifestyle, pre-existing conditions The Union Health Ministry on Tuesday clarified that there is no link between Covid-19 vaccines and sudden premature deaths among adults, citing various studies by Indian Council of Medical Research (ICMR) and National Centre for Disease Control (NCDC). Covid vaccines and sudden death concerns about the link between the two have been a topic of public interest. However, evidence consistently shows that Covid vaccination does not increase the risk of unexplained sudden death. 'The matter of sudden unexplained deaths has been investigated through several agencies in the country. These studies have conclusively established that there is no direct link between COVID 19 vaccination and the reports of sudden deaths in the country," the ministry said in a statement. The health ministry noted that the studies have shown that the sudden cardiac deaths can result from a wide range of factors, including genetics, lifestyle, pre-existing conditions, and post-Covid complications. 'Studies by the Indian Council of Medical Research (ICMR) and National Centre for Disease Control (NCDC) affirm that COVID-19 vaccines in India are safe and effective, with extremely rare instances of serious side effects. Sudden cardiac deaths can result from a wide range of factors, including genetics, lifestyle, pre-existing conditions, and post-COVID complications," the press release added. The two studies, done by ICMR and NCDC, offer a more comprehensive understanding of sudden unexplained deaths in young adults in India. As per the studies, it has been revealed that Covid-19 vaccination does not appear to increase the risk, whereas, the role of underlying health issues, genetic predisposition and risky lifestyle choices does play a role in unexplained sudden deaths. Scientific experts have reiterated that statements linking Covid vaccination to sudden deaths are false and misleading, and are not supported by scientific consensus. Speculative claims without conclusive evidence risk undermining public confidence in vaccines, which have played a crucial role in saving millions of lives during the pandemic. Such unfounded reports and claims could strongly contribute to vaccine hesitancy in the country, thereby adversely impacting public health. The government's response came after Karnataka Chief Minister Siddaramaiah recently alleged that 'hasty approval and distribution" of the Covid vaccine to the public could also be a reason for the recent deaths due to heart attacks in Hassan. At least 22 people, including five aged between 19 and 25, have died due to heart attacks in Hassan district over the last 40 days, officials familiar with the development said, adding that most of the deaths happened without any visible symptoms, with several collapsing at home or in public spaces. In a statement issued on Tuesday, Siddaramaiah said, 'In the past month alone, in just one district of Hassan, more than twenty people have died due to heart attacks. The government is taking this matter very seriously…To identify the exact cause of these series of deaths and to find solutions, a committee of experts has been formed under the leadership of Dr Ravindranath, Director of Jayadeva Institute of Cardiovascular Sciences and Research, and they have been instructed to submit a study report within 10 days." According to him, orders were given to the same committee back in February to conduct a thorough study on the reasons behind sudden deaths among young people in the state, and whether the COVID vaccines could have had any adverse effects. In this regard, the process of examining and analysing heart patients is also underway. 'We too value the lives of children, youth, and innocent people who have their entire lives ahead of them, and we share the concerns of their families," he said. (With inputs from agencies)
